Le Lézard
Classified in: Health, Science and technology, Business
Subjects: LIC, TRI

Trial Library Announces Expansion of Collaboration to Advance Equity and Access in Oncology Clinical Trials


SAN FRANCISCO, March 21, 2024 /PRNewswire/ -- Trial Library, Inc., an oncology clinical trials company, announced today it has expanded a collaboration with Johnson & Johnson Innovative Medicine applying the Trial Library platform in support of oncology clinical development and medical affairs programs.

Trial Library's platform is integrated with technology-enabled navigation services to advance equity and access to clinical trials. Trial Library's platform is available to a diverse community-based provider network as a recruitment solution that can assist in identifying patients from community-based practices to receive navigation support to trial sites.

Trial Library provides insights to study teams regarding study design, eligibility criteria, and recommendations on diverse trial sites from the Trial Library community provider network. Trial Library's software solution supports healthcare provider information regarding clinical trial options available at the point-of-care.

"We are delighted to continue to work with Johnson & Johnson as we look to leverage our capabilities and change the standard practice for recruiting diverse populations to clinical trials," said Trial Library CEO Dr. Hala Borno.

About Trial Library

Trial Library is a technology company that supports equitable access to oncology clinical trials.

Media Contact: [email protected] 

SOURCE Trial Library, Inc


These press releases may also interest you

at 06:35
KalVista Pharmaceuticals to Present at Upcoming Investor Conferences
KalVista Pharmaceuticals, Inc. , a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of oral, small molecule protease inhibitors, today announced its management will participate in fireside chats at...

at 06:30
10 Fitness Introduces Gated Amenities for Enhanced Member Experience and Unmatched Safety
10 Fitness is taking the member experience to new heights with the introduction of gated amenities, ensuring unparalleled access control and safety within its clubs. This move sets a new industry standard, distinguishing 10 Fitness from traditional...

at 06:10
Next Generation Drug Conjugates Market Worth USD 7.94 Billion to 2031 - Exclusive Report by InsightAce Analytic Pvt. Ltd.
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Next Generation Drug Conjugates Market ? By Type (Peptide Receptor Radionuclide Therapy, Ligand mediated RNAi Conjugate, Ligand Conjugated Anti Sense...

at 06:07
Seed Health Launches VS-01, A First-of-its Kind Vaginal Microbiome Innovation to Redefine Vaginal Care
An optimal vaginal microbiome is a key driver of gynecological, urogenital, and reproductive health  VS-01tm is a multi-strain probiotic and prebiotic clinically validated to establish an optimal vaginal microbiome and sustain regulated vaginal pH...

at 06:05
Ironwood Late-Breaker Oral Presentation at Digestive Disease Week® Reinforces Potential of Once-Weekly Apraglutide for Adults with Short Bowel Syndrome with Intestinal Failure (SBS-IF)
Ironwood Pharmaceuticals, Inc. , a GI-focused healthcare company, will present late-breaking data during the 2024 Digestive Disease Week® (DDW) meeting from its pivotal Phase III clinical trial, STARS, which evaluated the efficacy and safety of...

at 06:05
Ellodi Pharmaceuticals Announces FLUTE-2 Data to be Presented at DDW 2024 with APT-1011 in Patients with Eosinophilic Esophagitis
Ellodi Pharmaceuticals, a gastroenterology-focused specialty pharmaceutical company, today announced an oral presentation by Professor Evan Dellon M.D., M.P.H, at the Digestive Disease Week (DDW) 2024 Annual Scientific Meeting. The presentation will...

More news about Health...


News published on and distributed by: